Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma's First Reboost Vacc-4x Study Accepted for Publication in the Vaccine Journal

Bionor Pharma ASA (OSE: BIONOR) announces that the results from the Company’s first re-boost clinical trial of Vacc-4x have been accepted for publication in the renowned journal Vaccine. 

The Phase II trial was conducted at Oslo University Hospital and completed in 2010. The trial investigated the effect of re-boosting 22 available patients from previous study with the Company’s leading therapeutic HIV vaccine candidate Vacc-4x.  The study demonstrated that it is possible to elicit strong memory immune responses up to 7 years after the initial vaccination. 

 

 

If you would like to read more, visit Bionor Pharam's website here.

Associated companies:


Related news

Latest news

World's fastest ROV? - Project ROST

Traditionally, all cleaning has been carried out from a workboat,

New regional manager takes the helm in key oil and gas markets for DNV GL

Elaborating on the differences in the energy markets which now lie under his new responsibilities in DNV GL,

DNV GL launches certification framework and recommended practice for Carbon Capture and Storage (CCS)

The recommended practice DNVGL-RP-F104 Design and operation of carbon dioxide pipelines, 

DNV GL launches new JDP to test biodegradable lubricants

The test programme will investigate such aspects as hydrodynamic oil film formation,

ROV contracts in Brazil

The new contracts and contract extensions give 1 630 days of ROV services...

Steinsvik Secures a Contract for its First Concrete Barge

Steinsvik’s well-known steel barge design is now complemented by a new and innovative concrete barge design.

Searching for the best biological solutions

AKVA group’s biologists play a key role to ensure that the company’s technology not only meets fish welfare requirements, but also provides the best possible conditions for the fish.

Elisabeth Maråk Støle appointed managing director of Forskningsselskapet SørVest AS

Elisabeth Maråk Støle will take up her position on 1 April 2018 at the latest.

TIME SCALE

We are building chambers for tomatoes to grow in space. The aim is to give food to astronauts going to Mars.